recombinant human GM-CSF-encoding oncolytic adenovirus SynOV1.1
Term · Oncology and biomedicine · MLC-T-ONC-016417
A recombinant oncolytic adenovirus, controlled by synthetic gene circuit, encoding the human immunostimulating factor cytokine granulocyte-macrophage colony stimulating factor (GM-CSF), with potential immunostimulating and antineoplastic activities. Upon administration, the recombinant human GM-CSF-encoding oncolytic adenovirus SynOV1.1 selectively targets, infects and replicates in tumor cells expressing the tumor-associated antigen (TAA) alpha-fetoprotein (AFP), thereby expressing GM-CSF and inducing tumor cell lysis. The lysis of cancer cells causes the release of cancer-specific antigens, and triggers systematic anti-tumor immune responses. In addition, GM-CSF attracts dendritic cells (DCs) and may further stimulate a cytotoxic T-cell response against tumor cells, which results in immune-mediated tumor cell death. The gene circuit contains a synthetic sensory switch that is under the control of a cancer-specific AFP promoter and multiple microRNA inputs. The gene circuits are triggered to activate viral replication and express hGM-CSF in AFP-expressing cancer cells, but not in normal cells.
| Identifier | MLC-T-ONC-016417 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | oncolytic virotherapeutic SynOV1.1 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-016417",
"term": "recombinant human GM-CSF-encoding oncolytic adenovirus SynOV1.1",
"field": "Oncology and biomedicine",
"definition": "A recombinant oncolytic adenovirus, controlled by synthetic gene circuit, encoding the human immunostimulating factor cytokine granulocyte-macrophage colony stimulating factor (GM-CSF), with potential immunostimulating and antineoplastic activities. Upon administration, the recombinant human GM-CSF-encoding oncolytic adenovirus SynOV1.1 selectively targets, infects and replicates in tumor cells expressing the tumor-associated antigen (TAA) alpha-fetoprotein (AFP), thereby expressing GM-CSF and inducing tumor cell lysis. The lysis of cancer cells causes the release of cancer-specific antigens, and triggers systematic anti-tumor immune responses. In addition, GM-CSF attracts dendritic cells (DCs) and may further stimulate a cytotoxic T-cell response against tumor cells, which results in immune-mediated tumor cell death. The gene circuit contains a synthetic sensory switch that is under the control of a cancer-specific AFP promoter and multiple microRNA inputs. The gene circuits are triggered to activate viral replication and express hGM-CSF in AFP-expressing cancer cells, but not in normal cells.",
"synonyms": [
"oncolytic virotherapeutic SynOV1.1"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/recombinant-human-gm-csf-encoding-oncolytic-adenovirus-synov1-1/"
}
Record 14,160 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.